Not Yet Recruiting
Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differentiated Thyroid Carcinoma
NCT06848920
- Conditions
- Differentiated Thyroid Carcinoma (DTC), Neoadjuvant Therapy
- Locations
-
- The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China